In the pharmaceutical industry, regulatory compliance is the line between success and setbacks—and Lyomac has built its legacy on mastering this critical requirement. Since 2009, we have delivered over 200 freeze drying systems to more than 15 countries, each fully compliant with cGMP, GAMP5, and FDA standards. What makes our approach stand out is that compliance isn’t an afterthought—it’s woven into every stage of our process, from initial design to final validation. Our product range, spanning laboratory (up to 12L), pilot (up to 150L), and industrial (up to 1000L) freeze dryers, ensures that whether you’re a biotech startup in R&D or a multinational scaling commercial production, you never compromise on regulatory alignment.
Selecting the right freeze dryer is a critical decision for pharmaceutical companies—one that impacts product quality, compliance, and long-term costs. With so many options on the market, what separates the best from the rest? Industry leaders prioritize three core factors: reliability, customization, and service—and Lyomac excels in all three.
Pharmaceutical R&D is a journey—one that requires equipment that evolves with your needs. A freeze dryer that works for small-scale formulation development may not scale to commercial production, forcing companies to invest in multiple systems and rebuild processes. Lyomac solves this with a full product portfolio designed for seamless scalability, from laboratory to industrial scale.
Automation is reshaping pharmaceutical manufacturing, and freeze-drying is no exception. Manual loading/unloading, inconsistent parameter adjustments, and labor-intensive processes are being replaced by intelligent systems that boost productivity, reduce errors, and enhance sterility. Lyomac’s Auto Loading/Unloading Systems (ALAUS) are at the forefront of this transformation, designed to meet the demands of modern sterile production.
In the global pharmaceutical industry, GMP compliance is not just a regulatory requirement—it’s the foundation of product safety and market access. For biotech and nutraceutical enterprises, non-compliant freeze-drying processes can lead to costly delays, batch rejections, and even market bans. Since 2009, Lyomac has been a trusted partner in navigating these complexities, delivering over 200 GMP/FDA/GAMP5-compliant freeze-drying systems across 15+ countries.
In the biopharmaceutical and vaccine sectors, freeze-drying technology is the critical barrier to preserving drug activity and stability. Over 60% of biological products rely on lyophilization for global distribution, yet temperature fluctuations, inconsistent vacuum levels, or sterile control gaps often lead to costly batch failures. Since 2009, Zhejiang Lyomac Pharmaceutical Equipment Co., Ltd. has transformed this challenge into an opportunity, turning freeze-drying from an experience-driven process into a data-backed precision solution.
